Verona Pharma Statistics Share Statistics Verona Pharma has 84.98M
shares outstanding. The number of shares has increased by 738.45%
in one year.
Shares Outstanding 84.98M Shares Change (YoY) 738.45% Shares Change (QoQ) 0.42% Owned by Institutions (%) 10.63% Shares Floating 78.31M Failed to Deliver (FTD) Shares 1,234 FTD / Avg. Volume 0.04%
Short Selling Information The latest short interest is 2.08M, so 2.41% of the outstanding
shares have been sold short.
Short Interest 2.08M Short % of Shares Out 2.41% Short % of Float 2.51% Short Ratio (days to cover) 1.38
Valuation Ratios The PE ratio is -21.84 and the forward
PE ratio is 109.6.
Verona Pharma's PEG ratio is
-0.11.
PE Ratio -21.84 Forward PE 109.6 PS Ratio 89.56 Forward PS 14.4 PB Ratio 18.51 P/FCF Ratio -30.84 PEG Ratio -0.11
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Verona Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 10.63,
with a Debt / Equity ratio of 0.6.
Current Ratio 10.63 Quick Ratio 10.48 Debt / Equity 0.6 Debt / EBITDA -0.86 Debt / FCF -1 Interest Coverage -6.57
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $202.29K Profits Per Employee $-829.75K Employee Count 209 Asset Turnover 0.09 Inventory Turnover 0.41
Taxes Income Tax 6.69M Effective Tax Rate -4.1%
Stock Price Statistics The stock price has increased by 286.69% in the
last 52 weeks. The beta is 0.14, so Verona Pharma's
price volatility has been higher than the market average.
Beta 0.14 52-Week Price Change 286.69% 50-Day Moving Average 103.38 200-Day Moving Average 71.95 Relative Strength Index (RSI) 72.05 Average Volume (20 Days) 3,489,206
Income Statement In the last 12 months, Verona Pharma had revenue of 42.28M
and earned -173.42M
in profits. Earnings per share was -2.16.
Revenue 42.28M Gross Profit 39.7M Operating Income -154.63M Net Income -173.42M EBITDA -142.19M EBIT -139.59M Earnings Per Share (EPS) -2.16
Full Income Statement Balance Sheet The company has 399.76M in cash and 122.7M in
debt, giving a net cash position of 277.06M.
Cash & Cash Equivalents 399.76M Total Debt 122.7M Net Cash 277.06M Retained Earnings -562.4M Total Assets 572.87M Working Capital 497.61M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -122.2M
and capital expenditures -580K, giving a free cash flow of -122.78M.
Operating Cash Flow -122.2M Capital Expenditures -580K Free Cash Flow -122.78M FCF Per Share -1.51
Full Cash Flow Statement Margins Gross margin is 93.89%, with operating and profit margins of -365.73% and -410.18%.
Gross Margin 93.89% Operating Margin -365.73% Pretax Margin -385.84% Profit Margin -410.18% EBITDA Margin -336.31% EBIT Margin -365.73% FCF Margin -290.41%
